Abstract:[Objective]H9N2 subtype avian influenza virus can spread between the guinea pig after passages in guinea pigs continuously for 9 generations, showing that the capacity of H9N2 subtype avian influenza virus infection in mammals as well as the <br> spreading capacity between mammals are still very strong. Thus, this experiment using this strain virus A/Chicken/Jinan/Li-2/2010 (H9N2), JN, to study the molecular basis of H9N2 subtype influenza virus variation, and screen the pathogenicity related amino acid sites.[Method]An H9N2 subtype AIV was serial passaged in the lung of mice to acquire the variant strains JN-P9-2-M1, the mice were dissected, the lungs were removed, after grinding and centrifugation, the mice of next generation were inoculated intranasally, after nine generations of spreading, MDCK cells were used for virus multiplication. Then the full-length sequences of JN-P5-2-M1 and JN-P9-2-M1eight segments were amplified, cloned and analyzed. Amino acids encoded by each gene were deduced, compared to JN primary virus (P0) , and the nucleotide and amino acid changes in virus passages were obtained. The mice were dissected, the lung, liver, spleen, kidneys, brain and intestines were obtained, and the virus titer of tissues was titrated. Mice were anesthetized, and each virus dilution was used to inoculate intranasally three mice for detecting the survival rate and morbidity of mice. Lungs of mice were collected, then the pathological and immunohistochemical staining was made to compare the JN and JN-P9-2-M1 virus.[Result] JN-P9-2-M1 had high pathogenicity to mice, its MLD50 was 103.5EID50, when had a 106EID50, 105EID50, 104EID50 dose in mice, its survival rate was 0, at least 1000 times higher than JN, the JN in mice was not lethal. When the dose of JN-P9-2-M1 was 106-103EID50 for mice, the body weight was significantly reduced, and the clinical symptoms were obvious. After inoculation for 3-8 d the mice showed listless, hair messy, shortness of breath, arched, etc., but when the mice were inoculated with 106EID50JN virus, the mice body weight change rates were similar to the negative group. JN-P5-2-M1, JN-P9-2-M1, and JN could binding to SAa-2,6Gal receptor, like B influenza virus. JN virus was detected only in the lungs of mice, but JN-P9-2-M1 not only in the lungs of mice but also could be detected in liver, spleen, kidney and brain.[Conclusion]JN-P9-2-M1’s pathogenicity in mice significantly improved, compared with the original drug increased by at least 1 000 times. The three amino acid sites PB2 E627K, HA N313D, and HA N496S might be the reasons of preliminary improvement of the virus virulence in mice, and the two acid sites PA L342I and NA N218T might be possible to further improve the virus virulence in mice.

Mouse Models Choosing for the Comparative Study of Different Pathogenic Avian Influenza Viruses

Infection Of Inbred Balb/C And C57bl/6 And Outbred Institute Of Cancer Research Mice With The Emerging H7n9 Avian Influenza Virus

Mice as a Model for Studying the Avian H5N1 Influenza Virus in Mammals

Comparison of three mouse models infected with influenza virus by aerosol

Selection of H5N1 Subtype Avian Influenza Virus Demonstrating High Pathogenicity for Mice

Amino Acid Substitutions HA A150V, PA A343T, and PB2 E627K Increase the Virulence of H5N6 Influenza Virus in Mice

Differences in the Pathogenicity and Inflammatory Responses Induced by Avian Influenza A/H7N9 Virus Infection in BALB/c and C57BL/6 Mouse Models

Mouse-adapted H9N2 Avian Influenza Virus Causes Systemic Infection in Mice

Susceptibility of Mice Strains in Different Immune Status to Avian Influenza Virus H5N1 Infection and the Possible Mechanism

Adaptive Amino Acid Substitutions Enhance the Virulence of an Avian-Origin H6N1 Influenza Virus in Mice

Multiple Amino Acid Substitutions Involved in the Adaptation of Avian-Origin Influenza A (H10N7) Virus in Mice

The Adaptation of H9N2 Subtype AIV in Mouse and Analysis of Amino Acid Mutation

Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor.

Comparison of H7N9 and H9N2 influenza infections in mouse model unravels the importance of early innate immune response in host protection

Comparative pathogenicity of influenza virus-induced pneumonia mouse model following intranasal and aerosolized intratracheal inoculation

Multiple amino acid substitutions involved in the adaption of three avian-origin H7N9 influenza viruses in mice

Enhanced Pathogenicity and Transmissibility of H9N2 Avian Influenza Virus in Mammals by Hemagglutinin Mutations Combined with PB2-627K.

Acute Respiratory Distress Syndrome Induced by H9N2 Virus in Mice

Transcriptome Profiles of Highly Pathogenic Pure Avian H7N9 Virus-Infected Lungs of BALB/c Mice

Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies.

The mouse model for influenza